Company / Operating Margin
Sonoma Pharmaceuticals, Inc. Operating Margin History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-26.0%
FY2026
5-year range
-46.6% / -18.5%
FY2022-FY2026
Trend
+29.6%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -157.1% in FY2017 to -18.5% in FY2022.
Based on SEC 10-K filings.
-26.0% in FY2026 with a 5-year CAGR of +15.3%.
Improved from -34.4% to -26.0% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +20.7pp
- 5-Year Change
- +15.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2026, operating margin increased 29.6% year-over-year.
- Peak operating margin was recorded in FY2022.
- Lowest operating margin in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | -26.0% | +29.6% |
| FY2025 | -36.9% | -7.2% |
| FY2024 | -34.4% | +26.1% |
| FY2023 | -46.6% | -151.9% |
| FY2022 | -18.5% | +55.1% |
| FY2021 | -41.2% | +30.5% |
| FY2020 | -59.4% | +30.3% |
| FY2019 | -85.2% | +15.8% |
| FY2018 | -101.2% | +35.6% |
| FY2017 | -157.1% | -226.7% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026